Appointment of Joint Corporate Broker and Joint Financial Adviser
OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint Corporate Broker and Joint ...
Viralgen and CTNNB1 Foundation partner to manufacture a new gene therapy for CTNNB1 Syndrome
Viralgen and the CTNNB1 Foundation have come together to manufacture an investigational gene therapy designed to treat CTNNB1 ...